SN BIOLOGICS is a specialized biotechnology company that has developed proprietary ceramic source control technology based on 100% beta-TCP to overcome the limitations of conventional bone graft materials. Recognized with the NET (New Excellent Technology) certification by the Ministry of Health and Welfare, the company successfully commercialized NEO BONE, a next-generation bone graft material with superior physicochemical properties. In response to the aging population, SN BIOLOGICS continues to expand its innovative product pipeline and strives to become a leading global company in bone graft solutions.